Nadav Kidron - 26 May 2023 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Issuer symbol
ORMP
Transactions as of
26 May 2023
Net transactions value
$0
Form type
4
Filing time
31 May 2023, 17:10:18 UTC
Previous filing
20 Apr 2023
Next filing
08 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +120,000 +9% 1,452,098 26 May 2023 Direct F1
holding ORMP Common Stock 126,000 26 May 2023 By wholly-owned corporation
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.